These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10933653)

  • 21. Fluoroquinolone resistance of Serratia marcescens: involvement of a proton gradient-dependent efflux pump.
    Kumar A; Worobec EA
    J Antimicrob Chemother; 2002 Oct; 50(4):593-6. PubMed ID: 12356807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the mechanism of quinolone resistance in nalidixic acid-resistant clinical isolates of Salmonella serotype Typhimurium.
    Ruiz J; Castro D; Goñi P; Santamaria JA; Borrego JJ; Vila J
    J Med Microbiol; 1997 Jul; 46(7):623-8. PubMed ID: 9236748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of group A bacteriocins of Serratia marcescens by nalidixic acid.
    Traub WH; Kleber I; Schaber I
    Nat New Biol; 1973 Oct; 245(144):144-5. PubMed ID: 4582895
    [No Abstract]   [Full Text] [Related]  

  • 24. Selected and spontaneous variants of Serratia marcescens with combined resistance against chloramphenicol, nalidixic acid, and trimethoprim.
    Traub WH; Kleber I
    Chemotherapy; 1977; 23(6):436-51. PubMed ID: 336309
    [No Abstract]   [Full Text] [Related]  

  • 25. Intraphagocytic bactericidal activity of bacterial DNA gyrase inhibitors against Serratia marcescens.
    Traub WH
    Chemotherapy; 1984; 30(6):379-86. PubMed ID: 6097410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of suprainhibitory concentrations of quinolones on hydrophobicity and motility of Serratia marcescens.
    Majtán V; Majtánová L
    Microbios; 2000; 102(402):79-88. PubMed ID: 10885498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of the cell wall on ciprofloxacin susceptibility in selected wild-type Gram-negative and Gram-positive bacteria.
    Berlanga M; Montero MT; Hernández-Borrell J; Viñas M
    Int J Antimicrob Agents; 2004 Jun; 23(6):627-30. PubMed ID: 15194135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii.
    Navia MM; Ruiz J; Ribera A; de Anta MT; Vila J
    J Antimicrob Chemother; 1999 Dec; 44(6):743-8. PubMed ID: 10590274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Membrane permeability of Pseudomonas aeruginosa to 4-quinolones.
    Kubesch P; Wehsling M; Tümmler B
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jun; 265(1-2):197-202. PubMed ID: 3118593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nalidixic acid screening test for the detection of decreased susceptibility to ciprofloxacin in Salmonella typhi.
    Ciraj AM; Seema DS; Bhat GK; Shivananda PG
    Indian J Pathol Microbiol; 2001 Oct; 44(4):407-8. PubMed ID: 12035350
    [No Abstract]   [Full Text] [Related]  

  • 31. Analysis of acquired ciprofloxacin resistance in a clinical strain of Pseudomonas aeruginosa.
    Masecar BL; Celesk RA; Robillard NJ
    Antimicrob Agents Chemother; 1990 Feb; 34(2):281-6. PubMed ID: 2158277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance of shigella to nalidixic acid & fluorinated quinolones.
    Thirunarayanan MA; Jesudason MV; John TJ
    Indian J Med Res; 1993 Nov; 97():239-41. PubMed ID: 8144205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative antibacterial activity of fleroxacin: selection frequencies and outer membrane proteins of resistant mutants].
    Cullmann W; Dechène M; Stieglitz M
    Immun Infekt; 1988 Aug; 16(4):152-8. PubMed ID: 3141267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Site-directed mutagenesis studies to probe the role of specific residues in the external loop (L3) of OmpF and OmpC porins in susceptibility of Serratia marcescens to antibiotics.
    Begic S; Worobec EA
    Can J Microbiol; 2007 Jun; 53(6):710-9. PubMed ID: 17668031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alteration in expression of Serratia marcescens porins associated with decreased outer membrane permeability.
    Hashizume T; Sanada M; Nakagawa S; Tanaka N
    J Antimicrob Chemother; 1993 Jan; 31(1):21-8. PubMed ID: 8444671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tigecycline resistance in Serratia marcescens associated with up-regulation of the SdeXY-HasF efflux system also active against ciprofloxacin and cefpirome.
    Hornsey M; Ellington MJ; Doumith M; Hudson S; Livermore DM; Woodford N
    J Antimicrob Chemother; 2010 Mar; 65(3):479-82. PubMed ID: 20051474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iron transport systems of Serratia marcescens.
    Angerer A; Klupp B; Braun V
    J Bacteriol; 1992 Feb; 174(4):1378-87. PubMed ID: 1531225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Accumulation and efflux of quinolones by clinical isolates of Stenotrophomonas maltophilia].
    Sánchez P; Alonso A; Campanario E; Alós I; Martíinez JL
    Rev Esp Quimioter; 2000 Jun; 13(2):176-81. PubMed ID: 10918091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of Serratia marcescens ompF and ompC porin genes in response to osmotic stress, salicylate, temperature and pH.
    Begic S; Worobec EA
    Microbiology (Reading); 2006 Feb; 152(Pt 2):485-491. PubMed ID: 16436436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility.
    Hakanen AJ; Lindgren M; Huovinen P; Jalava J; Siitonen A; Kotilainen P
    J Clin Microbiol; 2005 Nov; 43(11):5775-8. PubMed ID: 16272517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.